Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Cell Science|July 17, 2008
EGF induces coalescence of different lipid raftsErik G Hofman, Mika O Ruonala, Arjen N Bader, et al.
Mabs|May 29, 2015
Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platformAlex Klarenbeek, Khalil El Mazouari, Aline Desmyter, et al.
Biomaterials|October 22, 2013
Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticlesRaimond Heukers, Isil Altintas, Smiriti Raghoenath, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2011
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PETMaria J W D Vosjan, Lars R Perk, Rob C Roovers, et al.
Structure (London, England : 1993)|June 22, 2024
Structural insights into the role and targeting of EGFRvIIIAtrish Bagchi, Steven E Stayrook, Katerina T Xenaki, et al.
Journal of Cell Science|September 15, 2005
Ubiquilin recruits Eps15 into ubiquitin-rich cytoplasmic aggregates via a UIM-UBL interactionElsa Regan-Klapisz, Irina Sorokina, Jarno Voortman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2012
Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effectsJeroen A J M van de Water, Tugba Bagci-Onder, Aayush S Agarwal, et al.
Immunity|January 22, 2013
Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptorDietmar M W Zaiss, Jorg van Loosdregt, Andrea Gorlani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 10, 2012
Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatmentRoy van der Meel, Sabrina Oliveira, Isil Altintas, et al.
Protein Engineering, Design & Selection : PEDS|March 7, 2016
Combining somatic mutations present in different in vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeuticsAlex Klarenbeek, Christophe Blanchetot, Georg Schragel, et al.
Pageof 4